<DOC>
	<DOCNO>NCT01900691</DOCNO>
	<brief_summary>The CLARITY study clinical trial approve US FDA study removal Evolution® Esophageal Stent-Fully Covered malignant benign indication .</brief_summary>
	<brief_title>Removal Evolution® Esophageal Stent - Fully Covered</brief_title>
	<detailed_description />
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Esophageal Stenosis</mesh_term>
	<mesh_term>Esophageal Fistula</mesh_term>
	<mesh_term>Esophageal Perforation</mesh_term>
	<criteria>Patient diagnose benign malignant stricture , fistula , perforation , leak Physician plan remove stent within duration study followup Patient &lt; 18 year age Patient unable unwilling provide write informed consent comply followup schedule Patient pregnant , lactate , plan pregnant within next 6 month Patient simultaneously participate another investigational drug device study Patient contraindicate upper GI endoscopy and/or procedure perform conjunction esophageal stent placement Patient know hypersensitivity contraindication study product , opinion investigator , adequately premedicated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Esophageal Fistula</keyword>
	<keyword>Esophageal Neoplasms</keyword>
	<keyword>Esophageal Perforation</keyword>
	<keyword>Esophageal Stenosis</keyword>
	<keyword>Stents</keyword>
</DOC>